Form D · Biotechnology

LabVoice Inc.

Carrboro, NC · CIK 0001951025

Offering snapshot reported Jun 23, 2026 · SEC filing

Reported sold
$1.2M
Offering amount: $1.2M
Investors reported
4
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Nov 24, 2024
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$600K$1.2MApr 1, 2025: $700,007.00Apr 1, 2025Jun 23, 2026: $1,200,000.00Jun 23, 2026

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$700,007 → $1,200,000

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jun 23, 2026Amendment$1,200,000$499,993vs Apr 1, 20254SEC filing
Apr 1, 2025Initial$700,007No comparison4SEC filing
Oct 18, 2022Initial$3,000,000No comparison9SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-542644

Source: Form D, filed Jun 23, 2026. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Frederic Bost Director, Executive
Mathew Hahn Director
Tim Harkness Director
Judy Ohm Hicks Director
Judy Ohrn Hicks Director
Michael Piraino Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
252 Sweet Bay Place
Carrboro, NC, 27510